CME Group (CME) Given New $175.00 Price Target at Barclays

CME Group (NASDAQ:CME) had its price target increased by Barclays from $170.00 to $175.00 in a research report issued on Friday. The brokerage presently has an “overweight” rating on the financial services provider’s stock. Barclays’ target price would suggest a potential upside of 9.99% from the company’s previous close.

A number of other research analysts also recently issued reports on CME. Royal Bank of Canada boosted their target price on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. Citigroup lifted their price objective on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, October 19th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a report on Tuesday, January 2nd. Finally, Berenberg Bank began coverage on shares of CME Group in a report on Thursday, January 25th. They issued a “hold” rating and a $170.00 price objective for the company. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. CME Group currently has a consensus rating of “Buy” and a consensus price target of $155.08.

CME Group (NASDAQ CME) traded up $0.20 during midday trading on Friday, reaching $159.11. 2,887,838 shares of the company were exchanged, compared to its average volume of 1,310,000. The firm has a market capitalization of $54,140.00, a P/E ratio of 13.33, a PEG ratio of 2.06 and a beta of 0.64. CME Group has a 52 week low of $114.82 and a 52 week high of $163.00. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.02. The company had revenue of $900.00 million during the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 326.58% and a return on equity of 54.48%. The firm’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.14 earnings per share. equities analysts predict that CME Group will post 4.75 earnings per share for the current year.

In other news, insider Jack J. Tobin sold 2,325 shares of the business’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $152.28, for a total transaction of $354,051.00. Following the completion of the sale, the insider now owns 17,574 shares of the company’s stock, valued at $2,676,168.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John W. Pietrowicz sold 7,500 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the sale, the chief financial officer now directly owns 32,376 shares of the company’s stock, valued at approximately $4,904,964. The disclosure for this sale can be found here. Insiders have sold 37,428 shares of company stock valued at $5,527,779 in the last three months. Corporate insiders own 0.57% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in CME. Quadrant Capital Group LLC increased its stake in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC acquired a new position in CME Group during the third quarter worth about $124,000. San Francisco Sentry Investment Group CA acquired a new position in CME Group during the second quarter worth about $129,000. People s United Financial Inc. boosted its position in CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares during the last quarter. Finally, Bank of Nova Scotia Trust Co. acquired a new position in CME Group during the third quarter worth about $165,000. 82.91% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “CME Group (CME) Given New $175.00 Price Target at Barclays” was first reported by American Banking and Market News and is the property of of American Banking and Market News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/02/cme-group-cme-given-new-175-00-price-target-at-barclays.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)